Article
Genotype dependent QSAR for HIV-1 protease inhibition.
Journal of medicinal chemistry - 24 Mar 2005
Boutton Carlo W, De Bondt Hendrik L, De Jonge Marc R
Abstract excerpt
The development of drug-resistant viruses limits the therapeutic success of anti-HIV therapies. Some of these genetic HIV-variants display complex mutational patterns in their pol gene that codes for protease and reverse transcriptase, the most investigated molecular targets for antiretroviral therapy. In this paper, we present a computational structure-based approach to predict the resistance of a HIV-1 protease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
